#Germany #Frankfurt #LOG Pharma #DOW HEALTH+ #Eco Packaging

LOG Pharma's Innovative Barrier Eco Packaging at CPHI Frankfurt 2025

LOG Pharma Primary Packaging is set to showcase its groundbreaking barrier eco packaging line, developed in collaboration with Dow, one of the world’s foremost materials science companies, at CPHI Frankfurt 2025. This prestigious event will be hosted in Frankfurt, Germany, from October 28-30, 2025.

A Step Towards Sustainability

As the pharmaceutical industry grapples with the challenges of maintaining the efficacy of sensitive drug formulations, LOG Pharma recognizes the urgent need for sustainable solutions that also guarantee performance. Their barrier eco line seeks to address these issues by combining top-notch protective capabilities with eco-friendly designs. At Stand 8.0D74, Zone Packaging, attendees will have the opportunity to explore this innovative leap in packaging technology.

Technological Advancements

The barrier eco line utilizes Dow's advanced pharma-grade HEALTH+ HDPE resins, resulting in bottles that provide exceptional protection against moisture and oxygen. This innovation ensures that drug formulations retain their stability and safety without the excessive use of materials. Notably, these bottles are 30% lighter than their standard counterparts, while offering moisture barrier performance that is double that of traditional HDPE containers. This strategic design enables manufacturers to reduce production and shipping costs while also mitigating their carbon footprint.

The Importance of Protection

In today’s pharmaceutical landscape, the importance of shielding sensitive formulations cannot be overstated. The ingress of oxygen or moisture can compromise active ingredients, ultimately undermining their efficacy and shelf life. LOG Pharma’s barrier eco packaging offers a critical solution that meets the enhanced needs for product protection while utilizing fewer resources.

Market Growth and Collaboration

According to market analyses, the global barrier resins market is poised to grow significantly—projected to increase from $12.4 billion in 2021 to $16.6 billion by 2026, with Dow being a key player in this arena. The partnership between LOG Pharma and Dow demonstrates the powerful potential when innovative materials science meets a shared vision for sustainability.

Zshelyz Jaynelle Lee, EMEA Senior Marketing Manager at Dow, remarked, “Collaborating with LOG Pharma has shown what’s possible when shared vision meets advanced materials science. By utilizing our innovative pharma-grade HEALTH+ Polymers, LOG has brought to life a bottle that is not only lighter but also maintains superior gas and moisture barrier performance.”

Commitment to Sustainability

Noam Nahari, VP Marketing and Business Development at LOG Pharma, stated, “Our mission at LOG is to make pharmaceutical packaging both sustainable and affordable. By merging our expertise with Dow’s innovative resins, we can provide barrier solutions that protect sensitive medications while supporting our customers' environmental goals.”

About LOG Pharma Primary Packaging

With over 50 years of dedicated service to the global pharmaceutical industry, LOG Pharma Primary Packaging offers a diverse range of both standard and customizable packaging solutions. The company operates manufacturing sites in Israel and Hungary and is a proud part of Perlen Packaging.

For inquiries or to schedule a meeting at CPHI 2025, interested parties can visit LOG Pharma's official website.

With its commitment to sustainability and innovation, LOG Pharma is setting the groundwork for the future of pharmaceutical packaging, ensuring that sensitive formulations are both protected and environmentally responsible.